HEAD AND NECK CANCER METASTATIC

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting HEAD AND NECK CANCER METASTATIC:

# Drug Count
0 BISOPROLOL FUMARATE 5
1 ASPIRIN 4
2 ASPIRIN 325 MG 4
3 ASPIRIN 81 MG 4
4 BRODALUMAB 4
5 PEMBROLIZUMAB 4
6 RAMIPRIL 4
7 RIBOCICLIB 4
8 CISPLATIN 3
9 ENZALUTAMIDE 3
See all common drugs associated with HEAD AND NECK CANCER METASTATIC

HEAD AND NECK CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRODALUMAB 4 0.0019
1 TALAZOPARIB 1 0.0005
2 DESONIDE 1 0.0002
3 NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE 1 0.0002
4 GOLIMUMAB 2 0.0002
5 AFATINIB 1 0.0002
6 RIBOCICLIB 4 0.0001
7 ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE 1 0.0001
8 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 1 0.0001
9 PEGFILGRASTIM 1 0.0001
See all drugs enriched for association with HEAD AND NECK CANCER METASTATIC